News | December 01, 2025
SciSparc acquires Xylo Technologies' innovative endoscopic portfolio
The MUSE system offers a minimally invasive solution for treating gastroesophageal reflux disease
The MUSE system offers a minimally invasive solution for treating gastroesophageal reflux disease
This relates to the manufacture and supply of Human Recombinant Insulin (rh- Insulin) and Biosimilar Pegfilgrastim Drug Substance to the United States
India's pharmaceutical sector is rapidly shifting from a generics-led foundation to an innovation-driven ecosystem
The trial tested six injectable doses and three oral doses over as long as 36 weeks
The study successfully met its primary endpoint, demonstrating similar rates of viral suppression for DOR/ISL compared to Biktarvy at 48 weeks
With US$ 30.46 billion in exports and robust manufacturing capabilities, the industry is poised to expand into high-value drugs while strengthening ESG and compliance standards
The data highlight sustained intraocular pressure (IOP) reduction, drop-free treatment outcomes, and strong visual performance
The new company aims to transform cutting-edge, highly scalable technologies into innovative drug discovery platforms
Agreements mark a major victory in the President’s long-term pledge to lower prescription drug costs for Americans
This approval is based on positive results from two Phase 3, global, double-blind, placebo-controlled trials
Subscribe To Our Newsletter & Stay Updated
